
Opinion|Videos|July 25, 2024
Fusion-Based Biopsies in Active Surveillance
Author(s)Kyrollis Attalla, MD
Kyrollis Attalla, MD, describes the role of fusion-based biopsies in active surveillance for patients with prostate cancer and how this technology has improved monitoring and treatment strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Is there a role for fusion-based biopsies in active surveillance for patients with prostate cancer?
- How has this technology improved surveillance strategies and informed treatment and management decisions?
- How has this technology improved surveillance strategies and informed treatment and management decisions?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5




















